Stifel Initiates Coverage On SpyGlass Pharma with Buy Rating, Announces Price Target of $42
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Stifel analyst Tom Stephan initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Buy rating and announces Price Target of $42.
Stifel analyst Tom Stephan initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Buy rating and announces Price Target of $42.